Abstract:Objective: To report on a patient with congenital muscular dystrophy (CMD) due to a missense variant of LMNA gene and explore its pathogenicity. Methods: The 1-year-and-1-month-old boy has presented with motor development delay and elevation of muscle enzymes for more than half a year. Congenital myopathy was suspected. Following muscle biopsy, HE staining, immunostaining and electron microscopy were conducted to clarify the clinical diagnosis. Meanwhile, DNA was extracted from the child and his parents' peripheral venous blood samples. Trio-whole exome sequencing (trio-WES) was carried out to detect pathogenic variant in the child. Candidate variant was verified by Sanger sequencing and bioinformatic analysis. Results: Both light and electron microscopy showed a large area of necrotic muscle tissues with infiltration of inflammatory cells. Immunohistochemistry revealed a large amount of muscle cells to be diffusely positive for Dysferlin. The patient's motor delays, elevations of muscle enzymes and histopathological results suggested a clinical diagnosis of CMD. A de novo missense c.1072G>A (p.E358K) variant was detected in the LMNA gene by trio-WES. The variant was unreported previously (PS2) and was absent from major allele frequency databases (PM2). It was a loss of function variant and was considered as hotspot variant in the LMNA gene (PM1) as the amino acid (E), located in position 358, was highly conserved, and change of this amino acid was found to cause destruction of the filament domain (AA: 30-386), which may result in serious damage to the intermediate filament protein. Furthermore, c.1072G>A (p. E358K) in LMNA gene was also predicted to be pathogenic based on MutationTaster, PROVEAN and PolyPhen-2 (PP3) analysis. According to the guidelines of the American College of Medical Genetics and Genomics (ACMG), the variant was classified to be likely pathogenic (PS2+PM1+PM2+PP3). Conclusion: The child's condition may be attributed to the de novo missense c.1072 G>A (p.E358K) variant of the LMNA gene. Above discovery has expanded the variant spectrum of the LMNA gene.

[Surgical treatment of vertigo].

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

Letter to the Editor: Comments on “obesity Associated with a Novel Mitochondrial Trnacys M.5802a>g Mutation in a Chinese Family”

A De Novo Novel Variant in the MT-TD Gene is Associated with Prominent Extra-Neurologic Manifestations

Obesity is Potentially Associated with a Novel Mitochondrial Trnagly 10029A>G Mutation in a Chinese Family

The mitochondrial tRNAGlu A14693G mutation may influence the phenotypic manifestation of ND1 G3460A mutation in a Chinese family with Leber’s hereditary optic neuropathy

The Novel A 4435 G Mutation in the Mitochondrial Trnamet May Modulate the Phenotypic Expression of the LHON-Associated ND 4 G 11778 A Mutation

A novel pathogenic mitochondrial DNA variant m.4344T>C in tRNA Gln causes developmental delay

A Novel TFG C.793c>g Mutation in a Chinese Pedigree with Charcot‐Marie‐Tooth Disease 2

Butorphanol does not reduce the minimum alveolar concentration of halothane in dogs.

Effect of immunization with porcine kappa-2-elastin on elastase-like activity in rabbit aorta.

Whole-exome Sequencing Reveals a Novel Mutation of MT-ND5 Gene in a Mitochondrial Cardiomyopathy Pedigree: Patients Who Show Biventricular Hypertrophy, Hyperlactacidemia, Pulmonary Hypertension, and Decreased Exercise Tolerance.

A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family

Indentification of novel MSTO1 compound heterozygous mutations in a Chinese family with recessive cerebellar atrophy and ataxia

Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA.

MT-ND6 gene mutation analysis in two Chinese patients with mitochondrial disease

A Novel Mitochondrial M.14430a>g (MT-ND6, P.w82r) Variant Causes Complex I Deficiency and Mitochondrial Leigh Syndrome

A novel compound heterozygous mutation of the MTO1 gene associated with complex oxidative phosphorylation deficiency type 10

Novel mutations m.3959G>A and m.3995A>G in mitochondrial gene MT-ND1 associated with MELAS.

[Analysis of a child with congenital muscular dystrophy due to a novel variant of the LMNA gene]

A Homoplasmic MT‐TV Mutation Associated with Mitochondrial Inheritance of Hereditary Spastic Paraplegia